Syndax Pharmaceuticals SNDX Insider Ownership

NASDAQ SNDX
$9.35 -0.20 (-2.09%)
As of: Nov 10, 2026 · 12:25 PM EST

Insider Holdings by Owner

1.69Mn Shares
Michael A Metzger484.84K28.6%
Dennis Podlesak239.76K14.2%
Keith A. Goldan139.25K8.2%
Keith Katkin124.00K7.3%
Pierre Legault114.00K6.7%
Other insiders (9)592.10K35.0%

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.80%
■0% pp QoQ
Shares Held by Insiders
1.60Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
89.15Mn
89,150,619 shares
Direct Holdings
1.60Mn
Indirect: 0
Net Open-Market Trades
-32.38K
net sold · -$784.78K in Sep 2026
Insiders Holding Shares
14
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Open-Market Insider Trades

Bought Sold
Latest quarter —
Net over range —
Net-buying quarters —

Insider Ownership Summary

In the last 12 months, insiders at Syndax Pharmaceuticals made open-market sales of $2.86 million (143.98K shares) and bought no shares on the open market.

Form 4 Holdings

Insiders Holding SNDX

Insiders 14
Shares held 1.69Mn
Of outstanding 1.90%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Michael A Metzger Chief Executive Officer 484,843 0 484,843 28.6% 09 Jul, 2026
2 Dennis Podlesak Director 239,763 0 239,763 14.2% 30 Oct, 2026
3 Keith A. Goldan Chief Financial Officer 139,252 0 139,252 8.2% 02 Jun, 2026
4 Keith Katkin Director 124,000 0 124,000 7.3% 06 Feb, 2026
5 Pierre Legault Director 114,000 0 114,000 6.7% 06 Feb, 2026
6 Jennifer Jarrett Director 114,000 0 114,000 6.7% 06 Feb, 2026
7 Martin H. Jr. Huber Director 103,000 0 103,000 6.1% 06 Feb, 2026
8 William Meury Director 90,000 0 90,000 5.3% 07 Feb, 2025
9 Neil Gallagher President, Head Of Rd 85,095 0 85,095 5.0% 12 Feb, 2025
10 Nicholas A.J. Botwood Head Of Rd, Cmo 60,885 0 60,885 3.6% 12 Jun, 2026
11 Aleksandra Rizo Director 49,000 0 49,000 2.9% 06 Feb, 2026
12 Briggs Morrison President, Head Of Rd 34,836 0 34,836 2.1% 09 Feb, 2024
13 Fabrice Egros Director 32,000 0 32,000 1.9% 03 Feb, 2022
14 Michael L. Meyers Svp, Chief Medical Officer 23,280 0 23,280 1.4% 03 Feb, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

549 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
29 Oct, 2026 Dennis Podlesak Director Acquired M 8,000 $11.81 $94.48K 247,763 Direct
29 Oct, 2026 Dennis Podlesak Director Disposed S 8,000 $14.21 $113.72K 239,763 Direct
29 Oct, 2026 Dennis Podlesak Director Disposed M 8,000 $0.00 $0 0 Direct
08 Jul, 2026 Michael A Metzger Chief Executive Officer Acquired M 32,375 $6.38 $206.55K 517,218 Direct
08 Jul, 2026 Michael A Metzger Chief Executive Officer Disposed S 32,375 $24.24 $784.78K 484,843 Direct
08 Jul, 2026 Michael A Metzger Chief Executive Officer Acquired M 32,375 $0.00 $0 0 Direct
11 Jun, 2026 Nicholas A.J. Botwood Head Of Rd, Cmo Acquired M 22,515 $13.82 $311.16K 95,165 Direct
11 Jun, 2026 Nicholas A.J. Botwood Head Of Rd, Cmo Disposed S 34,280 $18.00 $617.04K 60,885 Direct
12 Jun, 2026 Nicholas A.J. Botwood Head Of Rd, Cmo Acquired M 31,235 $13.82 $431.67K 92,120 Direct
12 Jun, 2026 Nicholas A.J. Botwood Head Of Rd, Cmo Disposed S 31,235 $18.14 $566.60K 60,885 Direct
11 Jun, 2026 Nicholas A.J. Botwood Head Of Rd, Cmo Acquired M 22,515 $0.00 $0 0 Direct
12 Jun, 2026 Nicholas A.J. Botwood Head Of Rd, Cmo Acquired M 31,235 $0.00 $0 0 Direct
01 Jun, 2026 Keith A. Goldan Chief Financial Officer Disposed S 1,177 $18.99 $22.35K 139,252 Direct
01 Jun, 2026 Michael A Metzger Chief Executive Officer Disposed S 6,847 $18.99 $130.02K 484,843 Direct
09 Feb, 2026 Michael A Metzger Chief Executive Officer Disposed S 17,159 $21.03 $360.82K 491,690 Direct
09 Feb, 2026 Keith A. Goldan Chief Financial Officer Disposed S 3,410 $21.03 $71.71K 140,429 Direct
04 Feb, 2026 Dennis Podlesak Director Acquired A 48,000 $0.00 $0 239,763 Direct
04 Feb, 2026 Michael A Metzger Chief Executive Officer Acquired A 73,000 $0.00 $0 371,661 Direct
04 Feb, 2026 Pierre Legault Director Acquired A 24,000 $0.00 $0 114,000 Direct
04 Feb, 2026 Keith Katkin Director Acquired A 24,000 $0.00 $0 124,000 Direct